- Filed
- May 2, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 16.19M sh |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $80.98M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $90.43M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $237.61M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $160.57M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $8.61B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $8.56B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $9.81B |
| Total Assets | Q1 2025 · Mar 31, 2024 | $9.88B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 16.19M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $3.14M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $35.01M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $2.17 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $2.18 |
| Net Income | Q1 2025 · Mar 31, 2024 | $35.2M |
| Revenue | Q1 2025 · Mar 31, 2024 | $152.84M |